Results 31 to 40 of about 4,141 (163)

Efficacy of auranofin as an inhibitor of desmoid progression

open access: yesScientific Reports, 2022
Anticancer drugs and molecular targeted therapies are used for refractory desmoid-type fibromatosis (DF), but occasionally cause severe side effects. The purpose of this study was to identify an effective drug with fewer side effects against DF by drug ...
Kan Ito   +12 more
doaj   +1 more source

Auranofin Has Advantages over First-Line Drugs in the Treatment of Severe Streptococcus suis Infections

open access: yesAntibiotics, 2020
Streptococcal toxic shock-like syndrome (STSLS) likely occurs when an individual is infected with the Streptococcus suis (S. suis) epidemic strain and is characterized by a cytokine storm, multiple organ dysfunction syndrome (MODS) and a high incidence ...
Hao Lu   +10 more
doaj   +1 more source

Auranofin coated catheters inhibit bacterial and fungal biofilms in a murine subcutaneous model

open access: yesFrontiers in Cellular and Infection Microbiology, 2023
Microbe entry through catheter ports can lead to biofilm accumulation and complications from catheter-related bloodstream infection and ultimately require antimicrobial treatment and catheter replacement.
LewisOscar Felix   +7 more
doaj   +1 more source

Comprehensive chemical proteomics for target deconvolution of the redox active drug auranofin

open access: yesRedox Biology, 2020
Chemical proteomics encompasses novel drug target deconvolution methods in which compound modification is not required. Herein we use Thermal Proteome Profiling, Functional Identification of Target by Expression Proteomics and multiplexed redox ...
Amir Ata Saei   +8 more
doaj   +1 more source

Cyclic Voltammetry of Auranofin [PDF]

open access: yesMetal-Based Drugs, 1999
The oxidative behavior of Auranofin, 2,3,4,6‐tetra‐O‐acetyl‐1‐thio‐β ‐D‐glucopyranosato‐ S(triethylphosphine)gold(I), was investigated by using cyclic voltammetry (CV) in 0.1 M Bu4NPF6/CH2Cl2 and 0.1 M Bu4NPF4/CH2Cl2 solutions using Pt working and auxiliary electrodes and a Ag/AgCI reference.
Mohamed, Ahmed A.   +2 more
openaire   +2 more sources

Advancing Therapies for Mycobacterial Diseases: From Small Molecules to Host‐Directed Strategies

open access: yesMedicinal Research Reviews, EarlyView.
ABSTRACT The global burden of multidrug‐resistant tuberculosis (MDR‐TB) and the rising incidence of nontuberculous mycobacterial (NTM) infections highlight the urgent need for innovative therapeutic strategies. Current treatments are prolonged, toxic, and increasingly compromised by resistance and limited diagnostic capacity.
Tânia Silva   +23 more
wiley   +1 more source

RNA‐binding protein RBMS1: A new target for cancer diagnosis and treatment

open access: yesPrecision Medical Sciences, EarlyView.
This schematic illustrates the diverse regulatory roles of RNA‐binding motif single‐stranded interacting protein 1 (RBMS1) across multiple human cancers. In breast cancer, RBMS1 stabilizes B4GALT1 mRNA to promote PD‐L1 glycosylation, modulating tumor immune escape and immunotherapy efficacy.
Xingda Run   +7 more
wiley   +1 more source

Synergistic Dual Targeting of Thioredoxin and Glutathione Systems Irrespective of p53 in Glioblastoma Stem Cells

open access: yesAntioxidants
Glioblastoma (GBM) is an incurable primary brain cancer characterized by increased reactive oxygen species (ROS) production. The redox-sensitive tumor suppressor gene TP53, wild-type (wt) for 70% of patients, regulates redox homeostasis.
Fatemeh Jamali   +5 more
doaj   +1 more source

Mitochondrial physiology in cardiac muscle of deer mice native to high altitude

open access: yesThe Journal of Physiology, EarlyView.
Abstract figure legend High‐altitude deer mice exhibited evolved changes in mitochondrial energy metabolism and reactive oxygen species (ROS) management that may support cardiac performance under cold hypoxic conditions. High‐altitude mice had increased activity of lactate dehydrogenase (LDH) in the heart, probably enhancing the capacity for lactate ...
Ranim Saleem   +3 more
wiley   +1 more source

Prdx5 in the Regulation of Tuberous Sclerosis Complex Mutation-Induced Signaling Mechanisms

open access: yesCells, 2023
(1) Background: Tuberous sclerosis complex (TSC) mutations directly affect mTORC activity and, as a result, protein synthesis. In several cancer types, TSC mutation is part of the driver mutation panel.
Judit Bovari-Biri   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy